These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11322940

  • 1. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.
    Yin D, Tang JG.
    FEBS Lett; 2001 Apr 20; 495(1-2):16-20. PubMed ID: 11322940
    [Abstract] [Full Text] [Related]

  • 2. Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.
    Wang LY, Sun W, Chen MZ, Wang X.
    Sheng Li Xue Bao; 2003 Dec 25; 55(6):641-7. PubMed ID: 14695479
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
    Croze F, Prud'homme GJ.
    J Gene Med; 2003 May 25; 5(5):425-37. PubMed ID: 12731091
    [Abstract] [Full Text] [Related]

  • 4. Insulin delivery with plasmid DNA.
    Abai AM, Hobart PM, Barnhart KM.
    Hum Gene Ther; 1999 Nov 01; 10(16):2637-49. PubMed ID: 10566891
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mice body weight gain is prevented after naked human leptin cDNA transfer into skeletal muscle by electroporation.
    Wang XD, Liu J, Yang JC, Chen WQ, Tang JG.
    J Gene Med; 2003 Nov 01; 5(11):966-76. PubMed ID: 14601134
    [Abstract] [Full Text] [Related]

  • 8. Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle.
    Martinenghi S, Cusella De Angelis G, Biressi S, Amadio S, Bifari F, Roncarolo MG, Bordignon C, Falqui L.
    Gene Ther; 2002 Nov 01; 9(21):1429-37. PubMed ID: 12378405
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector.
    Yoo HS, Mazda O, Lee HY, Kim JC, Kwon SM, Lee JE, Kwon IC, Jeong H, Jeong YS, Jeong SY.
    J Control Release; 2006 May 01; 112(1):139-44. PubMed ID: 16530875
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Recombination of RegIII-proinsulin-pBudCE4.1 plasmid and its therapeutic effect on STZ-induced type 1 diabetes mellitus].
    Hou WR, Xie SN, Lu JL, Xi W, Luo X, Xiang M.
    Yao Xue Xue Bao; 2010 Aug 01; 45(8):987-94. PubMed ID: 21351584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.
    Park YM, Woo S, Lee GT, Ko JY, Lee Y, Zhao ZS, Kim HJ, Ahn CW, Cha BS, Kim KS, Park CW, Lee HC.
    J Gene Med; 2005 May 01; 7(5):621-9. PubMed ID: 15651056
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitus.
    Yasutomi K, Itokawa Y, Asada H, Kishida T, Cui FD, Ohashi S, Gojo S, Ueda Y, Kubo T, Yamagishi H, Imanishi J, Takeuchi T, Mazda O.
    Biochem Biophys Res Commun; 2003 Oct 24; 310(3):897-903. PubMed ID: 14550289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.